A Phase 3, Open Label, Single Arm Trial Evaluating the Safety, Tolerability, and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine [pneumococcal 13-valent CRM197 vaccine conjugate] in Healthy Infants Given With Routine Pediatric Vaccinations in Mexico.
Phase of Trial: Phase III
Latest Information Update: 24 Oct 2011
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 24 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Feb 2011 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 09 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.